Citations

Mayo Clinic

Clear

205 citation(s) found for "Ismail, M".

Abscopal Effect Following Cryoablation in a Patient with Metastatic Breast Cancer
Kaplan, Jamie L. , Türker, İsmail , Chumsri, Saranya , Turker, Ismail, Gabriel, Emmanuel

Frontiers in Bioscience-Scholar | January 18, 2023 | Volume: 15 | Issue: 1 | Pages: No page available

10.31083/j.fbs1501002 | PMID 36959110 Get It

While breast cancer is a common disease with many available treatment options, many patients still have limited responses, especially those with metastatic breast cancer. Surgery of the primary tumor or metastatic sites is often not part of the treatment regimen for patients with metastatic breast cancer. Cryoablation is a relatively non-invasive procedure that is being investigated for patients with breast cancer. Patients with metastatic breast cancer who are not surgical candidates may derive benefit from cryoablation through the abscopal effect. In this case report, we present a patient with stage IV breast cancer who was treated with cryoablation of the primary breast tumor and showed evidence of an abscopal effect in regional and distant metastases.
13-Year Analysis of Gender Disparity in Peer Reviewed Burn Literature
Khan, Iman F. , Ketheeswaran, Suvethavarshini, Willey, Brea, Alasgarov, Elvin, Turker, Ismail, Guliyeva, Günel , Hultman, C. Scott, Cooney, Carisa M. , Caffrey, Julie , Cooney, Carisa M , Turker, Ismail

Journal of Burn Care & Research | January 16, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/jbcr/irad003 | PMID 36645329 Get It

Abstract Women are less likely to be senior authors, invited to write in scientific journals, and to be cited in high impact journals. The aim of this study was to investigate trends in authorship and gender differences in peer-reviewed burn literature over 13 years. We performed a retrospective analysis of original research articles published from January 2009 to September 2021 in three burn journals. A gender determination application was used to categorize the gender of the first and senior author. Of the 3,908 articles analyzed, 42.5% had a woman first author and 27.6% had a woman senior author. We identified 2,029 unique senior authors, 29.0% of whom were women. Woman senior authorship was associated with increased odds of woman first authorship [OR=2.31 (95% CI 2.00, 2.67); p<0.001]. The percentage of papers with a woman senior author increased from 17.8% in 2009 to 35.7% in 2021. If this 1.0% (95% CI: 0.50 – 1.51%) linear trend increase per year in woman senior authorship continues, we will expect to see equal proportions of woman and man senior authors in the included journals starting in 2037. The field of burn care is far from reaching gender parity with respect to authorship of peer-reviewed publications. Supporting and encouraging gender concordant and discordant first:last authorship dyads in mentorship as well as redistributing obligations that may detract from authorship opportunities are potential ways to improve parity in authorship and academia.
Single-Cell Dissection of Primary Quadruplet- and Triplet-Resistant Multiple Myeloma
Ismail, Wazim Mohammed , Maia, Alexandre Gaspar, Kumar, Shaji , Mohammed Ismail, Wazim , Binder, Moritz , Mazzone, Amelia , Fernandez, Jenna , Rajkumar, S. Vincent

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9978-9979

10.1182/blood-2022-162679 Get It

Identification of IL-4 As a Key Regulator of CAR T-Cell Exhaustion Using Functional Genomics and Correlates of the Zuma-1 Clinical Trial
Stewart, Carli M. , Ogbodo, Ekene J. , Manriquez-Roman, Claudia, Yun, Kun , Sirpilla, Olivia , Girsch, James H. , Huynh, Truc, Mattie, Mike , Filosto, Simone, Stewart, Carli , Cox, Michelle J. , Sakemura, Reona , Can, İsmail , Huynh, Truc , Siegler, Elizabeth L. , Kim, Jaeyeon , Scholler, Nathalie , Kenderian, Saad S.

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4536-4537

10.1182/blood-2022-160219 Get It

Chimeric Antigen Receptor Engineering of Mesenchymal Stromal Cells (CAR-MSC) Enhance Immunosuppression and Outcomes in Graft Versus Host Disease (GvHD) Preclinical Models
Sirpilla, Olivia , Girsch, James H. , Huynh, Truc, Schick, Kendall J. , Manriquez-Roman, Claudia, Yun, Kun , Stewart, Carli M. , Ogbodo, Ekene J. , Sakemura, Reona , Hefazi, Mehrdad , Huynh, Truc , Cox, Michelle J. , Can, İsmail , Stewart, Carli , Siegler, Elizabeth L. , Kenderian, Saad S.

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1579-1580

10.1182/blood-2022-158872 Get It

CD19 Antigen Occupancy on Cancer Cells with the CD19 Monoclonal Antibody Tafasitamab Improves the Activation, Antitumor Efficacy, and Safety Profile of CART19 Cell Therapy
Manriquez-Roman, Claudia, Horvei, Paulina , Huynh, Truc, Girsch, James H. , Sirpilla, Olivia , Yun, Kun , Stewart, Carli M. , Ogbodo, Ekene J. , Fonkoua, Lionel Aurelien Kankeu , Ruff, Michael W. , Ilieva-Babinsky, Kristina, Patra-Kneuer, Maria , Heitmüller, Christina, Ding, Wei , Nowakowski, Grzegorz S. , Sakemura, Reona , Cox, Michelle J. , Huynh, Truc , Stewart, Carli , Can, İsmail , Adada, Mohamad M , Hefazi, Mehrdad , Augsberger, Christian , Steidl, Stefan, Parikh, Sameer A. , Kay, Neil E. , Siegler, Elizabeth L. , Kenderian, Saad S.

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2362-2364

10.1182/blood-2022-158273 Get It

Targeting a Dominant Negative Splice Variant of TRAIL to Enhance CART Cell Functions
Natesampillai, Sekar, Manriquez-Roman, Claudia, Jalali, Shahrzad , Huynh, Truc, Krogman, Ashton , Maynes, Mark , Can, İsmail , Sakemura, Reona , Siegler, Elizabeth L. , Huynh, Truc , Maynes, Mark A , Badley, Andrew D. , Kenderian, Saad S. , Hefazi, Mehrdad

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 632-633

10.1182/blood-2022-163677 Get It

The safety and effectiveness of the Contour Neurovascular System for the treatment of wide-necked aneurysms: A systematic review and meta-analysis of early experience
Ghozy, Sherief , Lashin, Basant Ismail , Elfil, Mohamed , Bilgin, Cem , Kobeissi, Hassan , Kadirvel, Ramanathan , Kallmes, David F. , Kadirvel, Ram , Kallmes, David F , Ghozy, Sherief , Kobeissi, Hassan , Elfil, Mohamed , Lashin, Basant , Bilgin, Cem , Shehata, Mostafa

Interventional Neuroradiology | November 17, 2022 | Volume: 30 | Issue: 4 | Pages: 496-505

10.1177/15910199221139546 | PMID 36384322 Get It

Background The Contour is a new generation intrasaccular flow disruption tool that aims to cover the aneurysm neck and is sized according to the neck diameter. While several case series have been published, no literature review has been performed on this promising device. Objective To assess the safety and effectiveness profile of the Contour Neurovascular System for wide-necked aneurysms. Methods We followed the recommendations of the PRISMA checklist Four databases were searched with a supplemental manual search. All data were analyzed using R software version 4.2.1. Results We finally included six studies with 131 treated aneurysms. The overall procedural time was 97.27 (95% CI = 70.07–124.47) minutes, ranging from 78.9 to 136.0 min. The pooled adequate occlusion rate was 84.21% (95% CI = 75.45–90.25), and the overall functional independence rate was 94.74% (87.97–97.79). The overall adverse event rate was 4.70 (95% CI = 3.24–6.76), varying among different events from 0.78 to 8.53%. Thromboembolic events were the most commonly encountered in 8.53% of the patients (95% CI = 4.78–14.74), followed by headache and minor stroke with incidence rates of 5.88 (95% CI = 2.83–11.83) and 4.35 (95% CI = 1.41–12.63), respectively. The overall procedural time in studies using the Contour system only was 86.17 (95% CI = 68.70–10.64) minutes, while it was 136 (95% CI = 90.96–181.04) in the Contour-assisted coiling procedures. However, both techniques were comparable regarding adequate occlusion rates and functional independence. Conclusion With the anticipation of future studies, the Contour Neurovascular System is a safe and effective treatment option for wide-necked intracranial aneurysms.